2025 Research Grant Applications Open

We are pleased to announce applications for our 2025 research grant are open.

To find out how to apply please download our application pack.

Download application pack

Download the 2025 DRWA Research Grant Application pack

Research that’s changing lives.

Since 1976, DRWA has awarded $26m in funding to over 80 research projects in Western Australia. The researchers and the programs we support are committed to not only finding a cure to diabetes, but also treatments and breakthroughs that aim to reduce the long-term effects of diabetes.

All research projects funded by DRWA are conducted in WA. Additionally, when selecting where to distribute our funding we will look favourably at collaborative research that has the infrastructure to support its completion. Projects can focus on all forms and types of diabetes and previous conditions.

For 2022, $120,000 in funding has been awarded to two WA-based projects. The first is a fresh pilot study into the use of oral insulin in type 1 diabetes, carried out by Dr Mary Abraham from Perth Children’s Hospital and the Telethon Kids Institute. The second grant was awarded to Professor Kevin Pfleger and his team at the Harry Perkins Institute of Medical Research, who will investigate a new way to tackle disease-inducing chronic inflammation linked to type 2 diabetes.

In recent years Diabetes Research WA has awarded two annual research grants, however in the current economic environment for not-for-profit organisations, a prudent decision has been made to offer one grant for 2023. Notwithstanding this, the Board of DRWA reserves the right to exercise its discretion to award more than one research grant in this round should circumstances justify.

In 2024 we awarded our grant to Dr Danuta Sampson, for her study on The Harmonisation of Multi-Site OCTA Datasets for Advanced Biomarker Discovery. You can read more about her research here. 

 

Donate now

 

 

2024

Fundamental/Basic Science

Pioneering Diabetic Retinopathy Research in Western Australia: The Harmonisation of Multi-Site OCTA Datasets for Advanced Biomarker Discovery

Learn more

2023

Clinical/translational Research

Medication used to lower blood glucose levels in type 2 diabetes.

Learn more

2022

Clinical/Translational Research

A pilot study into the use of oral insulin in type 1 diabetes.

Learn more
Fundamental/Basic Science

Investigating a new way to tackle disease-inducing chronic inflammation linked to type 2 diabetes.

Learn more

2021

Fundamental/Basic Science

Investigating how a single gene change causes insulin resistance and type 2 diabetes.

Learn more
Clinical/Translational Research

A world-leading trial that could reduce the chances of people with type 2 diabetes who’ve had a heart attack suffering further heart failure.

Learn more

2020

Clinical/Translational Research

WA team's bid to simplify screening for pregnancy related diabetes.

Learn more
Fundamental/Basic Science

New project investigates wonder drug's potential to reduce blindness.

Learn more

2019

Clinical/Translational Research

New type 1 diabetes project could help kids at high-risk.

Learn more
Fundamental/Basic Science

Diabetes grant helps WA team race to create new type 2 treatment.

Learn more
Extended Research

‘Firefighting’ protein holds hope for new type 2 diabetes treatment.

Learn more

2018

Clinical/Translational Research

New WA Grant aims to prevent diabetes sight-loss V2.

Learn more
Fundamental/Basic Science

Prescribed statins, gut microbiota and increased risk of type 2 diabetes.

Learn more